InsidersTradesSigma
Sopharma AD: directors' dealings · Bulgaria · BSE-Sofia (FSC)
BSE-BG:sopharma-adBG·BSE-Sofia (FSC)Mcap 3.9Bn€Healthcare
Explore the full directors' dealings record of Sopharma AD, a listed equity based in Bulgaria. Shares are listed on BG BG, under the authority of BSE-Sofia (FSC). Operating in the Healthcare sector, Sopharma AD has published 149 insider filings. Market capitalisation: €3.9bn. The latest transaction was disclosed on 21 May 2026 — MAR Art. 17 — Insider information. The full history is openly available.
149
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
7.42 €
Analyst consensus
Income statement
Revenue2.61 Bn€
Gross profit604.1 M€23% margin
Net income133.5 M€5.1% margin
Valuation
PER (trailing)5.8x
P/Book4.0x
Beta0.07
Balance sheet & cash
Market cap3.90 Bn€
Total debt612.9 M€
Free Cash Flow−124.3 M€
Debt / Equity62%
Profitability & ownership
ROE15.5%
ROA4.3%
% insiders66.4%
% institutions0.2%
Last declaration on 21 May 2026
Declarations0 total
No declarations found
0 of 0 declarations
About Sopharma AD
Sopharma AD is a Bulgarian company engaged in the production and distribution of pharmaceuticals. It is listed on the Bulgarian Stock Exchange under the symbol XBUL.